Baker McKenzie acted as legal advisor to Xbrane. Xbrane Biopharma AB (publ) completed a primary issuance of shares of approximately SEK 125 million where the subscription...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here